Brief: Hua Medicine Initiates First Combination Study Of Dorzagliatin With A Dpp-4 Inhibitor In United States
01/02/2019 12:50
Feb 1 (Reuters) - Hua Medicine 2552.HK :
* HUA MEDICINE INITIATES FIRST COMBINATION STUDY OF
DORZAGLIATIN
WITH A DPP-4 INHIBITOR IN UNITED STATES
Source text for Eikon: ID:nGNXbVt0Dz
Further company coverage: 2552.HK
((Briefs@thomsonreuters.com;))
Recent news on Hua Medicine
See all newsBrief: Hua Medicine Expects Loss Of RMB30.2 Mln For HY
Brief: Hua Medicine Posts Profit For The Year RMB1.11 Billion
Brief: Hua Medicine Says Dorzagliatin Approved For Marketing In Hong Kong SAR
Brief: Hua Medicine Posts H1 Revenue Of RMB 217.4 Million
Brief: Hua Medicine Expects RMB1,184.1 Million Profit For HY